2021
DOI: 10.1001/jamanetworkopen.2021.35397
|View full text |Cite
|
Sign up to set email alerts
|

Factors Associated With Risk of Postdischarge Thrombosis in Patients With COVID-19

Abstract: Key Points Question Which patients with COVID-19 may benefit from extended thromboprophylaxis following hospital discharge? Findings In this cohort study of 2832 patients hospitalized with COVID-19, postdischarge venous thromboembolic events occurred more often in those with a history of venous thromboembolism, peak dimerized plasmin fragment D (D-dimer) level greater than 3 μg/mL, and predischarge C-reactive protein level greater than 10 mg/dL. Patients wh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
38
0
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 51 publications
(44 citation statements)
references
References 27 publications
0
38
0
2
Order By: Relevance
“…The relationship between a history of VTE and thrombosis in COVID-19 patients has been previously described [16]; thus, one of the factors that may have played a significant role in the association between Spanish and thrombosis was that seven of the eight subjects with a previous VTE were from Spain. Interestingly, the odds of thrombosis were 4.7 times higher in current smokers compared with former and non-smokers, coinciding with previous reports that indicate that, despite controversial findings, current, former, and heavy smokers have an elevated risk for thrombotic events [17][18][19][20][21].…”
Section: Discussionmentioning
confidence: 83%
“…The relationship between a history of VTE and thrombosis in COVID-19 patients has been previously described [16]; thus, one of the factors that may have played a significant role in the association between Spanish and thrombosis was that seven of the eight subjects with a previous VTE were from Spain. Interestingly, the odds of thrombosis were 4.7 times higher in current smokers compared with former and non-smokers, coinciding with previous reports that indicate that, despite controversial findings, current, former, and heavy smokers have an elevated risk for thrombotic events [17][18][19][20][21].…”
Section: Discussionmentioning
confidence: 83%
“…Fourth, the immune response against SARS-CoV-2 led to hypercoagulability or dysfunctional thrombocytes and thus to intra-atrial or intra-arterial thrombus formation. Arguments in favor of this hypothesis are that thrombus formation is a well-known complication of SARS-CoV-2 infections [ 5 - 6 ] and that embolic stroke has been repeatedly reported in association with SARS-CoV-2 infection [ 1 - 2 ]. Fifth, the infection with SARS-CoV-2 caused cerebral vasculitis, endothelialitis, or endothelial dysfunction, which are suspected to contribute to the pathophysiology of ischemic stroke in COVID-19 patients [ 7 ].…”
Section: Discussionmentioning
confidence: 99%
“…Hence, thrombosis prophylaxis regimen has been recommended in moderate and severe cases 21 . In outpatient settings, thrombosis prophylaxis has been even suggested for high‐risk individuals 22 . Overall, several mechanisms have been speculated for thrombus formation in COVID‐19 patients including endothelial dysfunction, intercellular junction abnormalities, formation of microthrombi, coagulopathies, immune‐induced thrombosis, cytokine storm, and inflammation 21,23 …”
Section: Discussionmentioning
confidence: 99%